Axonis Therapeutics Announces $115 Million Series A Financing Oct 30, 2024 06:00AM
venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies Aug 1, 2024 08:00AM
RayzeBio (RYZB): venBio Global Strategic Fund III Reports 8.5% Passive Stake Feb 9, 2024 04:41PM
Form SC 13G RayzeBio, Inc. Filed by: venBio Global Strategic Fund III, L.P. Feb 9, 2024 04:38PM
Form 4 RayzeBio, Inc. For: Sep 19 Filed by: venBio Global Strategic Fund III, L.P. Sep 21, 2023 04:31PM